Unknown

Dataset Information

0

Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines.


ABSTRACT: Recently, there has been an increasing interest for utilizing the host immune system to fight against cancer. Moreover, cancer vaccines, which can stimulate the host immune system to respond to cancer in the long term, are being investigated as a promising approach to induce tumor-specific immunity. In this work, we prepared an effective cancer vaccine (denoted as "vacosome") by reconstructing the cancer cell membrane, monophosphoryl lipid A as a toll-like receptor 4 agonist, and egg phosphatidylcholine. The vacosome triggered and enhanced bone marrow dendritic cell maturation as well as stimulated the antitumor response against breast cancer 4T1 cells in vitro. Furthermore, an immune memory was established in BALB/c mice after three-time preimmunization with the vacosome. After that, the immunized mice showed inhibited tumor growth and prolonged survival period (longer than 50 days). Overall, our results demonstrate that the vacosome can be a potential candidate for clinical translation as a cancer vaccine.

SUBMITTER: Cheng R 

PROVIDER: S-EPMC7549091 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines.

Cheng Ruoyu R   Fontana Flavia F   Xiao Junyuan J   Liu Zehua Z   Figueiredo Patrícia P   Shahbazi Mohammad-Ali MA   Wang Shiqi S   Jin Jing J   Torrieri Giulia G   Hirvonen Jouni T JT   Zhang Hongbo H   Chen Tongtong T   Cui Wenguo W   Lu Yong Y   Santos Hélder A HA  

ACS applied materials & interfaces 20200922 40


Recently, there has been an increasing interest for utilizing the host immune system to fight against cancer. Moreover, cancer vaccines, which can stimulate the host immune system to respond to cancer in the long term, are being investigated as a promising approach to induce tumor-specific immunity. In this work, we prepared an effective cancer vaccine (denoted as "vacosome") by reconstructing the cancer cell membrane, monophosphoryl lipid A as a toll-like receptor 4 agonist, and egg phosphatidy  ...[more]

Similar Datasets

| S-EPMC4233189 | biostudies-literature
| S-EPMC3262944 | biostudies-literature
| S-EPMC4494347 | biostudies-literature
| S-EPMC5928416 | biostudies-literature
| S-EPMC7823124 | biostudies-literature
2018-03-28 | GSE111730 | GEO
| S-EPMC2835315 | biostudies-literature
| S-EPMC3166201 | biostudies-literature
| S-EPMC4074652 | biostudies-literature
| S-EPMC5595996 | biostudies-literature